\-\ Texto\\:\\ \ \(0\)\
\-\ pale\\,\\ right\\ upper\\ quadrant\\ tenderness\\ to\\ palpation\\ 2\\/5\\,\\ hypochromic\\ microcytic\\ anemia\ \(0\)\
\-\ this\\ patient\\ was\\ enrolled\\ in\\ the\\ memorial\\ sloan\\ kettering\\ cancer\\ center\\ p6\\ protocol\\ for\\ dsrct\\ that\\ was\\ the\\ standard\\ of\\ therapy\\ at\\ that\\ time\\.\\ this\\ protocol\\ involved\\ seven\\ rounds\\ of\\ combination\\ chemotherapy\\ with\\ surgery\\ occurring\\ after\\ the\\ third\\ round\\ of\\ treatment\\ and\\ then\\ an\\ autologous\\ stem\\ cell\\ transplant\\ at\\ the\\ end\\ of\\ the\\ treatment\\ cycle\\.\\ this\\ patient\\ also\\ received\\ aggressive\\ post\\-surgical\\ radiation\\ therapy\\ of\\ 3\\,000\\ cgy\\.\\ \ \(0\)\
\-\ \\ \\ \\ the\\ patient\\ initially\\ tolerated\\ the\\ therapy\\ well\\,\\ but\\ was\\ found\\ to\\ have\\ tumor\\ recurrence\\ within\\ a\\ year\\ of\\ ending\\ the\\ protocol\\.\\ the\\ subsequent\\ treatment\\ course\\ encountered\\ multiple\\ complications\\ that\\ lead\\ to\\ urosepsis\\ and\\ eventually\\ the\\ death\\ of\\ the\\ patient\\ 2\\ years\\ and\\ 11\\ months\\ after\\ the\\ initial\\ diagnosis\\.\ \(0\)\
\-\ abdominal\\ ultrasound\\ \\â\\€\\“\\ hepatosplenomegaly\\,\\ and\\ 2\\ hypoechoic\\ homogenous\\ pelvic\\ masses\\ with\\ greatest\\ diameters\\ at\\ 6cm\\ and\\ 4cm\\.\\ \ \(0\)\
\-\ ct\\ abdomen\\ and\\ pelvis\\ \\â\\€\\“\\ multiple\\ soft\\ tissue\\ masses\\ with\\ the\\ largest\\ in\\ the\\ region\\ of\\ the\\ tail\\ of\\ the\\ pancreas\\ encasing\\ the\\ celiac\\ axis\\,\\ the\\ superior\\ mesenteric\\ artery\\,\\ and\\ the\\ renal\\ and\\ splenic\\ vessels\\.\\ several\\ lesions\\ in\\ the\\ right\\ lobe\\ of\\ the\\ liver\\ and\\ one\\ lesion\\ in\\ the\\ left\\ lobe\\ of\\ the\\ liver\\.\ \(0\)\
\-\ desmoplastic\\ small\\ round\\ cell\\ tumor\ \(0\)\
\-\ desmoplastic\\ small\\ round\\ cell\\ tumor\\ \\(dsrct\\)\\;\\ primitive\\ neuroectodermal\\ tumor\\ \\(pnet\\)\\;\\ undifferentiated\\ sarcoma\\;\\ lymphoma\\;\\ infection\\ \\(i\\.e\\.\\ mycobacterium\\-avium\\ intracellulare\\)\ \(0\)\
\-\ 15\\ year\\ old\\ previously\\ healthy\\ male\\ presents\\ with\\ two\\ weeks\\ of\\ fatigue\\ and\\ weakness\\,\\ anemia\\ requiring\\ transfusions\\,\\ and\\ splenomegaly\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ dsrct\\:\\ 0\\.06653221452050187\ \(0\)\
\-\ protocol\\:\\ 0\\.05203031002404216\ \(0\)\
\-\ desmoplastic\\:\\ 0\\.04777820206927168\ \(0\)\
\-\ round\\:\\ 0\\.04179118239128195\ \(0\)\
\-\ memorial\\:\\ 0\\.033266107260250935\ \(0\)\
\-\ sloan\\:\\ 0\\.033266107260250935\ \(0\)\
\-\ kettering\\:\\ 0\\.033266107260250935\ \(0\)\
\-\ p6\\:\\ 0\\.033266107260250935\ \(0\)\
\-\ mycobacterium\\-avium\\:\\ 0\\.033266107260250935\ \(0\)\
\-\ intracellulare\\:\\ 0\\.033266107260250935\ \(0\)\
\-\ anemia\\:\\ 0\\.032084303641499334\ \(0\)\
\-\ hypochromic\\:\\ 0\\.030650457522288878\ \(0\)\
\-\ 3\\,000\\:\\ 0\\.030650457522288878\ \(0\)\
\-\ diameters\\:\\ 0\\.030650457522288878\ \(0\)\
\-\ \\;\\:\\ 0\\.03057239529739764\ \(0\)\
\-\ tumor\\:\\ 0\\.03007143096771036\ \(0\)\
\-\ microcytic\\:\\ 0\\.029120400510559957\ \(0\)\
\-\ \\â\\€\\“\\:\\ 0\\.029024189618041492\ \(0\)\
\-\ enrolled\\:\\ 0\\.02719275664729207\ \(0\)\
\-\ cgy\\:\\ 0\\.02719275664729207\ \(0\)\
\-\ urosepsis\\:\\ 0\\.02719275664729207\ \(0\)\
\-\ rounds\\:\\ 0\\.0265047507725979\ \(0\)\
\-\ cell\\:\\ 0\\.026131026923563994\ \(0\)\
\-\ therapy\\:\\ 0\\.02586385807064845\ \(0\)\
\-\ 6cm\\:\\ 0\\.02457710690933001\ \(0\)\
\-\ encasing\\:\\ 0\\.024217445853464633\ \(0\)\
\-\ 2\\/5\\:\\ 0\\.02388910103463584\ \(0\)\
\-\ autologous\\:\\ 0\\.02388910103463584\ \(0\)\
\-\ undifferentiated\\:\\ 0\\.02388910103463584\ \(0\)\
\-\ neuroectodermal\\:\\ 0\\.022803508308402706\ \(0\)\
\-\ transfusions\\:\\ 0\\.02235904402290692\ \(0\)\
\-\ liver\\:\\ 0\\.022235634044020555\ \(0\)\
\-\ ending\\:\\ 0\\.022155016772830407\ \(0\)\
\-\ splenomegaly\\:\\ 0\\.02196145717136795\ \(0\)\
\-\ masses\\:\\ 0\\.021800697343366697\ \(0\)\
\-\ pale\\:\\ 0\\.021434053615235277\ \(0\)\
\-\ hepatosplenomegaly\\:\\ 0\\.02127345129667378\ \(0\)\
\-\ cycle\\:\\ 0\\.021119406034333196\ \(0\)\
\-\ post\\-surgical\\:\\ 0\\.020971403343188737\ \(0\)\
\-\ primitive\\:\\ 0\\.020971403343188737\ \(0\)\
\-\ encountered\\:\\ 0\\.020828987011177996\ \(0\)\
\-\ 4cm\\:\\ 0\\.020828987011177996\ \(0\)\
\-\ tolerated\\:\\ 0\\.020307664979174914\ \(0\)\
\-\ seven\\:\\ 0\\.020187858570440646\ \(0\)\
\-\ celiac\\:\\ 0\\.0198496994810456\ \(0\)\
\-\ treatment\\:\\ 0\\.019580569353972305\ \(0\)\
\-\ pnet\\:\\ 0\\.01953936703486835\ \(0\)\
\-\ stem\\:\\ 0\\.01916169360635143\ \(0\)\
\-\ homogenous\\:\\ 0\\.01916169360635143\ \(0\)\
\-\ largest\\:\\ 0\\.018283873624205197\ \(0\)\
\-\ occurring\\:\\ 0\\.01800931002313943\ \(0\)\
\-\ transplant\\:\\ 0\\.017815750421676973\ \(0\)\
\-\ greatest\\:\\ 0\\.017815750421676973\ \(0\)\
\-\ requiring\\:\\ 0\\.017815750421676973\ \(0\)\
\-\ eventually\\:\\ 0\\.01775337569733278\ \(0\)\
\-\ tail\\:\\ 0\\.01775337569733278\ \(0\)\
\-\ splenic\\:\\ 0\\.017456089365811594\ \(0\)\
\-\ death\\:\\ 0\\.017399342658775595\ \(0\)\
\-\ lobe\\:\\ 0\\.017353398852253087\ \(0\)\
\-\ i\\.e\\:\\ 0\\.017234049743083544\ \(0\)\
\-\ fatigue\\:\\ 0\\.017234049743083544\ \(0\)\
\-\ axis\\:\\ 0\\.017180522818585595\ \(0\)\
\-\ that\\:\\ 0\\.016709215795005547\ \(0\)\
\-\ standard\\:\\ 0\\.01650138553764597\ \(0\)\
\-\ pancreas\\:\\ 0\\.01650138553764597\ \(0\)\
\-\ end\\:\\ 0\\.016370496639578458\ \(0\)\
\-\ combination\\:\\ 0\\.016243995914904334\ \(0\)\
\-\ center\\:\\ 0\\.0158133796629518\ \(0\)\
\-\ aggressive\\:\\ 0\\.01577656390844099\ \(0\)\
\-\ lead\\:\\ 0\\.015460451142156238\ \(0\)\
\-\ received\\:\\ 0\\.014986155990595875\ \(0\)\
\-\ mesenteric\\:\\ 0\\.014869136229303196\ \(0\)\
\-\ small\\:\\ 0\\.014857171957593349\ \(0\)\
\-\ 11\\:\\ 0\\.014755636398219127\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.014700141502408956\ \(0\)\
\-\ healthy\\:\\ 0\\.014538391674364494\ \(0\)\
\-\ sarcoma\\:\\ 0\\.01435804954668016\ \(0\)\
\-\ recurrence\\:\\ 0\\.014067630523524959\ \(0\)\
\-\ 2\\:\\ 0\\.013887581105739972\ \(0\)\
\-\ multiple\\:\\ 0\\.013583441535692596\ \(0\)\
\-\ previously\\:\\ 0\\.013546308491521875\ \(0\)\
\-\ involved\\:\\ 0\\.013526074743818534\ \(0\)\
\-\ after\\:\\ 0\\.013343405302710961\ \(0\)\
\-\ pelvic\\:\\ 0\\.013234908402133183\ \(0\)\
\-\ initially\\:\\ 0\\.013124454129302566\ \(0\)\
\-\ at\\:\\ 0\\.013106752673565656\ \(0\)\
\-\ vessels\\:\\ 0\\.012982037797291823\ \(0\)\
\-\ third\\:\\ 0\\.01292998752509433\ \(0\)\
\-\ patient\\:\\ 0\\.012929689523266234\ \(0\)\
\-\ 15\\:\\ 0\\.012861685481156149\ \(0\)\
\-\ complications\\:\\ 0\\.01277801054721531\ \(0\)\
\-\ subsequent\\:\\ 0\\.01255313470871627\ \(0\)\
\-\ course\\:\\ 0\\.012168043182851477\ \(0\)\
\-\ the\\:\\ 0\\.011998994521446767\ \(0\)\
\-\ weakness\\:\\ 0\\.011975891898220318\ \(0\)\
\-\ pelvis\\:\\ 0\\.011717326062609919\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.011558285981663642\ \(0\)\
\-\ then\\:\\ 0\\.011475346711026754\ \(0\)\
\-\ quadrant\\:\\ 0\\.011348588430136055\ \(0\)\
\-\ was\\:\\ 0\\.01118804742128702\ \(0\)\
\-\ this\\:\\ 0\\.010880798641292072\ \(0\)\
\-\ palpation\\:\\ 0\\.010762034265464347\ \(0\)\
\-\ initial\\:\\ 0\\.010685215635016256\ \(0\)\
\-\ cancer\\:\\ 0\\.010600623639112322\ \(0\)\
\-\ radiation\\:\\ 0\\.010582080187027684\ \(0\)\
\-\ several\\:\\ 0\\.010366388059329764\ \(0\)\
\-\ superior\\:\\ 0\\.01029714602661959\ \(0\)\
\-\ found\\:\\ 0\\.010162360809253253\ \(0\)\
\-\ tenderness\\:\\ 0\\.00980721631276088\ \(0\)\
\-\ renal\\:\\ 0\\.009688586979087054\ \(0\)\
\-\ artery\\:\\ 0\\.009601999970219618\ \(0\)\
\-\ ultrasound\\:\\ 0\\.009566500320778503\ \(0\)\
\-\ abdomen\\:\\ 0\\.00955239344488942\ \(0\)\
\-\ years\\:\\ 0\\.00946884202648484\ \(0\)\
\-\ infection\\:\\ 0\\.009373647449331347\ \(0\)\
\-\ two\\:\\ 0\\.00923521221741889\ \(0\)\
\-\ lymphoma\\:\\ 0\\.00921584390335655\ \(0\)\
\-\ weeks\\:\\ 0\\.009151991535476032\ \(0\)\
\-\ time\\:\\ 0\\.009107929159393633\ \(0\)\
\-\ region\\:\\ 0\\.009107929159393633\ \(0\)\
\-\ months\\:\\ 0\\.008807325640339876\ \(0\)\
\-\ one\\:\\ 0\\.008738608993625073\ \(0\)\
\-\ lesions\\:\\ 0\\.00863230379752433\ \(0\)\
\-\ \\(\\:\\ 0\\.008177679919741816\ \(0\)\
\-\ \\,\\:\\ 0\\.00817237933637094\ \(0\)\
\-\ \\)\\:\\ 0\\.008077785193735528\ \(0\)\
\-\ abdominal\\:\\ 0\\.008060072596687227\ \(0\)\
\-\ soft\\:\\ 0\\.007852553826390754\ \(0\)\
\-\ surgery\\:\\ 0\\.00783018514852934\ \(0\)\
\-\ upper\\:\\ 0\\.0077814358693159185\ \(0\)\
\-\ tissue\\:\\ 0\\.00764309882434941\ \(0\)\
\-\ and\\:\\ 0\\.007472071936054351\ \(0\)\
\-\ diagnosis\\:\\ 0\\.007404601248228\ \(0\)\
\-\ well\\:\\ 0\\.007294645105542079\ \(0\)\
\-\ year\\:\\ 0\\.007215888824701243\ \(0\)\
\-\ have\\:\\ 0\\.0069827852013777045\ \(0\)\
\-\ but\\:\\ 0\\.006877370947296369\ \(0\)\
\-\ right\\:\\ 0\\.006804767615927673\ \(0\)\
\-\ presents\\:\\ 0\\.006587336964180852\ \(0\)\
\-\ lesion\\:\\ 0\\.006568132928303602\ \(0\)\
\-\ in\\:\\ 0\\.006360712907777433\ \(0\)\
\-\ also\\:\\ 0\\.006357055070453401\ \(0\)\
\-\ within\\:\\ 0\\.00615143927692861\ \(0\)\
\-\ male\\:\\ 0\\.005830964293914993\ \(0\)\
\-\ of\\:\\ 0\\.00527564380972023\ \(0\)\
\-\ to\\:\\ 0\\.004834733303128146\ \(0\)\
\-\ ct\\:\\ 0\\.004510579824120917\ \(0\)\
\-\ an\\:\\ 0\\.004459112695414075\ \(0\)\
\-\ left\\:\\ 0\\.0036079444123506216\ \(0\)\
\-\ old\\:\\ 0\\.0033016399881594513\ \(0\)\
\-\ for\\:\\ 0\\.0027513515043121324\ \(0\)\
\-\ with\\:\\ 0\\.001766100771168147\ \(0\)\
\-\ a\\:\\ 0\\.0014966030257305709\ \(0\)\
\-\ \\.\\:\\ 0\\.001339605135748916\ \(0\)\
